| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
AnaptysBio Inc (NASDAQ: ANAB)
ANAB Technical Analysis
5
| As on 9th Jun 2023 ANAB STOCK Price closed @ 18.70 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 26.22 & Strong Sell for SHORT-TERM with Stoploss of 32.53 we also expect STOCK to react on Following IMPORTANT LEVELS. |
ANABSTOCK Price
| Open | 18.28 | Change | Price | % |
| High | 18.76 | 1 Day | 0.38 | 2.07 |
| Low | 18.02 | 1 Week | 0.05 | 0.27 |
| Close | 18.70 | 1 Month | -2.80 | -13.02 |
| Volume | 236185 | 1 Year | -16.86 | -47.41 |
| 52 Week High 37.07 | 52 Week Low 18.55 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| ANAB Daily Charts |
ANAB Intraday Charts |
Whats New @ Bazaartrend |
ANAB Free Analysis |
|
|
ANAB Important Levels Intraday
| RESISTANCE | 20.13 |
| RESISTANCE | 19.67 |
| RESISTANCE | 19.39 |
| RESISTANCE | 19.10 |
| SUPPORT | 18.30 |
| SUPPORT | 18.01 |
| SUPPORT | 17.73 |
| SUPPORT | 17.27 |
ANAB Forecast May 2024
| 4th UP Forecast | 31.05 |
| 3rd UP Forecast | 27.09 |
| 2nd UP Forecast | 24.64 |
| 1st UP Forecast | 22.19 |
| 1st DOWN Forecast | 15.21 |
| 2nd DOWN Forecast | 12.76 |
| 3rd DOWN Forecast | 10.31 |
| 4th DOWN Forecast | 6.35 |
ANAB Weekly Forecast
| 4th UP Forecast | 24.81 |
| 3rd UP Forecast | 22.85 |
| 2nd UP Forecast | 21.64 |
| 1st UP Forecast | 20.43 |
| 1st DOWN Forecast | 16.97 |
| 2nd DOWN Forecast | 15.76 |
| 3rd DOWN Forecast | 14.55 |
| 4th DOWN Forecast | 12.59 |
ANAB Forecast2024
| 4th UP Forecast | 56.05 |
| 3rd UP Forecast | 44.07 |
| 2nd UP Forecast | 36.67 |
| 1st UP Forecast | 29.26 |
| 1st DOWN Forecast | 8.14 |
| 2nd DOWN Forecast | 0.73 |
| 3rd DOWN Forecast | -6.67 |
| 4th DOWN Forecast | -18.65 |
AnaptysBio Inc ( NASDAQ USA Symbol : ANAB )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
ANAB Business Profile
AnaptysBio, Inc., a clinical stage biotechnology company, engages in developing therapeutic product candidates for inflammation and immuno-oncology indications. The company's products include Imsidolimab, an IL-36R antibody that inhibits the interleukin-36 receptor for the treatment of various dermatological inflammatory diseases; ANB030, an anti-PD-1 agonist antibody program designed to augment PD-1 signaling through ANB030 treatment to suppress T-cell driven human inflammatory diseases; and ANB032, an anti-BTLA modulator antibody applicable to human inflammatory diseases associated with lymphoid and myeloid immune cell dysregulation. It also focuses on developing various antibody programs that are advanced to preclinical and clinical milestones under its collaborations. AnaptysBio, Inc. has a collaboration and license agreement with TESARO, Inc. and Celgene Corporation; and license agreements with United Kingdom Research and Innovation, as well as Millipore Corporation. The company was formerly known as Anaptys Biosciences, Inc. and changed its name to AnaptysBio, Inc. in July 2006. AnaptysBio, Inc. was incorporated in 2005 and is headquartered in San Diego, California. Address: 10421 Pacific Center Court, San Diego, CA, United States, 92121
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service